Founded Year
2022Stage
Seed | AliveAbout Neomics Pharmaceuticals
Neomics Pharmaceuticals focuses on the development of adaptive immune cell products for the treatment of various solid tumors. The company was founded in 2022 and is based in Shanghai, China.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Neomics Pharmaceuticals Patents
Neomics Pharmaceuticals has filed 1 patent.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immune system
- Immunology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/4/2022 | Clusters of differentiation, Transcription factors, Immunology, Immune system, Proteins | Application |
Application Date | 1/4/2022 |
|---|---|
Grant Date | |
Title | |
Related Topics | Clusters of differentiation, Transcription factors, Immunology, Immune system, Proteins |
Status | Application |
Neomics Pharmaceuticals Frequently Asked Questions (FAQ)
When was Neomics Pharmaceuticals founded?
Neomics Pharmaceuticals was founded in 2022.
Where is Neomics Pharmaceuticals's headquarters?
Neomics Pharmaceuticals's headquarters is located at Room 1031, 10th Floor, No. 8 Jiafeng Road, Shanghai.
What is Neomics Pharmaceuticals's latest funding round?
Neomics Pharmaceuticals's latest funding round is Seed.
Who are the investors of Neomics Pharmaceuticals?
Investors of Neomics Pharmaceuticals include Shanghai Biomedical Industry Equity Investment Fund Management.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
